Astrocyte regulation of CNS inflammation and remyelination
- PMID: 24961523
- PMCID: PMC4061872
- DOI: 10.3390/brainsci3031109
Astrocyte regulation of CNS inflammation and remyelination
Abstract
Astrocytes regulate fundamentally important functions to maintain central nervous system (CNS) homeostasis. Altered astrocytic function is now recognized as a primary contributing factor to an increasing number of neurological diseases. In this review, we provide an overview of our rapidly developing understanding of the basal and inflammatory functions of astrocytes as mediators of CNS responsiveness to inflammation and injury. Specifically, we elaborate on ways that astrocytes actively participate in the pathogenesis of demyelinating diseases of the CNS through their immunomodulatory roles as CNS antigen presenting cells, modulators of blood brain barrier function and as a source of chemokines and cytokines. We also outline how changes in the extracellular matrix can modulate astrocytes phenotypically, resulting in dysregulation of astrocytic responses during inflammatory injury. We also relate recent studies describing newly identified roles for astrocytes in leukodystrophies. Finally, we describe recent advances in how adapting this increasing breadth of knowledge on astrocytes has fostered new ways of thinking about human diseases, which offer potential to modulate astrocytic heterogeneity and plasticity towards therapeutic gain. In summary, recent studies have provided improved insight in a wide variety of neuroinflammatory and demyelinating diseases, and future research on astrocyte pathophysiology is expected to provide new perspectives on these diseases, for which new treatment modalities are increasingly necessary.
Figures

Similar articles
-
Astrocytes as mediators of immune and inflammatory responses in the CNS.Neurotoxicology. 1998 Apr;19(2):269-81. Neurotoxicology. 1998. PMID: 9553964 Review.
-
Functional dissection of astrocyte-secreted proteins: Implications in brain health and diseases.Prog Neurobiol. 2018 Mar;162:37-69. doi: 10.1016/j.pneurobio.2017.12.003. Epub 2017 Dec 13. Prog Neurobiol. 2018. PMID: 29247683 Review.
-
The "molecular soldiers" of the CNS: Astrocytes, a comprehensive review on their roles and molecular signatures.Eur J Pharmacol. 2023 Nov 15;959:176048. doi: 10.1016/j.ejphar.2023.176048. Epub 2023 Sep 26. Eur J Pharmacol. 2023. PMID: 37758010 Review.
-
Important Shapeshifter: Mechanisms Allowing Astrocytes to Respond to the Changing Nervous System During Development, Injury and Disease.Front Cell Neurosci. 2018 Aug 21;12:261. doi: 10.3389/fncel.2018.00261. eCollection 2018. Front Cell Neurosci. 2018. PMID: 30186118 Free PMC article.
-
Astrocytes in rare neurological conditions: Morphological and functional considerations.J Comp Neurol. 2021 Jul 1;529(10):2676-2705. doi: 10.1002/cne.25118. Epub 2021 Feb 7. J Comp Neurol. 2021. PMID: 33496339 Review.
Cited by
-
Precision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive Astrocytes.Front Mol Neurosci. 2016 Sep 15;9:85. doi: 10.3389/fnmol.2016.00085. eCollection 2016. Front Mol Neurosci. 2016. PMID: 27695400 Free PMC article. Review.
-
TIMP-1 Attenuates the Development of Inflammatory Pain Through MMP-Dependent and Receptor-Mediated Cell Signaling Mechanisms.Front Mol Neurosci. 2019 Sep 20;12:220. doi: 10.3389/fnmol.2019.00220. eCollection 2019. Front Mol Neurosci. 2019. PMID: 31616247 Free PMC article.
-
Elucidating the Therapeutic Utility of Olaparib in Sulfatide-Induced Human Astrocyte Toxicity and Neuroinflammation.J Neuroimmune Pharmacol. 2023 Dec;18(4):592-609. doi: 10.1007/s11481-023-10092-9. Epub 2023 Nov 4. J Neuroimmune Pharmacol. 2023. PMID: 37924373 Free PMC article.
-
TIMP-1 couples RhoK activation to IL-1β-induced astrocyte responses.Neurosci Lett. 2015 Nov 16;609:165-70. doi: 10.1016/j.neulet.2015.10.038. Epub 2015 Oct 17. Neurosci Lett. 2015. PMID: 26484505 Free PMC article.
-
How do different cell populations orchestrate myelin regeneration?Biochem Soc Trans. 2025 Jun 30;53(3):653-669. doi: 10.1042/BST20231085. Biochem Soc Trans. 2025. PMID: 40552465 Free PMC article. Review.
References
-
- Shirani A., Zhao Y., Karim M.E., Evans C., Kingwell E., van der Kop M.L., Oger J., Gustafson P., Petkau J., Tremlett H. Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis. JAMA. 2012;308:247–256. doi: 10.1001/jama.2012.7625. - DOI - PubMed
-
- Stys P.K., Zamponi G.W., van Minnen J., Geurts J.J. Will the real multiple sclerosis please stand up? Nat. Rev. Neurosci. 2012;13:507–514. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical